Mereo BioPharma Group (MREO)
undefined
undefined%
At close: undefined
3.76
1.21%
After-hours Dec 13, 2024, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -29.47M -36.09M 14.24M -166.45M -41.12M -37.31M -46.95M -33.72M
Depreciation & Amortization 1.06M 727.00K 642.00K 1.60M 1.58M 37.80K 36.08K 32.94K
Stock-Based Compensation 4.92M 4.77M 4.46M 2.12M 1.64M 2.19M 3.65M 6.49M
Other Working Capital -786.00K 1.13M -1.26M -3.55M -6.73M - - -
Other Non-Cash Items 3.94M -9.14M 13.41M 5.22M -429.00K 1.92M 751.65K 179.76K
Deferred Income Tax - - -34.99M 133.14M 69.00K 7.62M 7.34M 1.60M
Change in Working Capital -1.59M 1.82M -1.84M -3.41M -7.67M 2.41M 3.02M -1.99M
Operating Cash Flow -21.13M -38.82M -5.24M -28.34M -45.93M -23.14M -32.15M -27.40M
Capital Expenditures -419.00K -10.00K -535.00K -16.00K -21.00K -35.54K -2.30M -3.47K
Acquisitions - - - -354.00K 10.07M - - -
Purchase of Investments - - - - - - -2.50M -
Sales Maturities Of Investments - - - - 32.87M - - -
Other Investing Acitivies -419.00K 1.51M 114.00K 1.86M 377.00K 287.09K 1.05M 376.08K
Investing Cash Flow -419.00K 1.50M -421.00K 1.50M 43.30M 251.56K -3.74M 372.61K
Debt Repayment -3.19M -1.13M -933.95K 30.65M -2.90M 577.35K 27.03M 4.27M
Common Stock Repurchased - - - - -1.31M -306.84K - -
Dividend Paid - - - - - - - -
Other Financial Acitivies -444.00K 349.96K -253.73K -23.35M -2.50M -2.61M -1.70M -3.70M
Financial Cash Flow 7.97M -784.00K 77.65M 34.74M -5.71M -2.07M 33.74M 68.36M
Net Cash Flow -10.76M -37.96M 70.83M 7.12M -8.70M -25.00M -3.53M 41.33M
Free Cash Flow -21.55M -38.83M -5.77M -28.36M -45.95M -23.17M -34.44M -27.40M